|
Name |
Eugenitol
|
| Molecular Formula | C11H10O4 | |
| IUPAC Name* |
5,7-dihydroxy-2,6-dimethylchromen-4-one
|
|
| SMILES |
CC1=CC(=O)C2=C(O1)C=C(C(=C2O)C)O
|
|
| InChI |
InChI=1S/C11H10O4/c1-5-3-8(13)10-9(15-5)4-7(12)6(2)11(10)14/h3-4,12,14H,1-2H3
|
|
| InChIKey |
HMAUJNAGOIPKDG-UHFFFAOYSA-N
|
|
| Synonyms |
EUGENITOL; 5,7-dihydroxy-2,6-dimethylchromen-4-one; 491-48-5; 5,7-dihydroxy-2,6-dimethylchromone; KBio2_001059; Spectrum_000579; SpecPlus_000031; Spectrum2_000749; Spectrum3_000183; Spectrum4_001500; Spectrum5_000239; 5,7-dihydroxy-2,6-dimethyl-4H-chromen-4-one; BSPBio_001705; KBioGR_002139; KBioSS_001059; DivK1c_006127; SPBio_000738; CHEMBL3039487; CHEBI:92806; KBio1_001071; KBio2_003627; KBio2_006195; KBio3_001205; DTXSID70407683; CCG-38991; SDCCGMLS-0066844.P001; NCGC00179070-01; 5,7-dihydroxy-2,6-dimethyl-1-benzopyran-4-one; BRD-K46068882-001-02-7; Q27164567
|
|
| CAS | 491-48-5 | |
| PubChem CID | 5036604 | |
| ChEMBL ID | CHEMBL3039487 |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 206.19 | ALogp: | 2.1 |
| HBD: | 2 | HBA: | 4 |
| Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 66.8 | Aromatic Rings: | 2 |
| Heavy Atoms: | 15 | QED Weighted: | 0.694 |
| Caco-2 Permeability: | -4.809 | MDCK Permeability: | 0.00001110 |
| Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.981 |
| Human Intestinal Absorption (HIA): | 0.014 | 20% Bioavailability (F20%): | 0.094 |
| 30% Bioavailability (F30%): | 0.838 |
| Blood-Brain-Barrier Penetration (BBB): | 0.016 | Plasma Protein Binding (PPB): | 91.65% |
| Volume Distribution (VD): | 0.604 | Fu: | 11.64% |
| CYP1A2-inhibitor: | 0.968 | CYP1A2-substrate: | 0.955 |
| CYP2C19-inhibitor: | 0.17 | CYP2C19-substrate: | 0.214 |
| CYP2C9-inhibitor: | 0.357 | CYP2C9-substrate: | 0.831 |
| CYP2D6-inhibitor: | 0.282 | CYP2D6-substrate: | 0.584 |
| CYP3A4-inhibitor: | 0.123 | CYP3A4-substrate: | 0.233 |
| Clearance (CL): | 6.335 | Half-life (T1/2): | 0.771 |
| hERG Blockers: | 0.017 | Human Hepatotoxicity (H-HT): | 0.058 |
| Drug-inuced Liver Injury (DILI): | 0.591 | AMES Toxicity: | 0.478 |
| Rat Oral Acute Toxicity: | 0.112 | Maximum Recommended Daily Dose: | 0.803 |
| Skin Sensitization: | 0.877 | Carcinogencity: | 0.104 |
| Eye Corrosion: | 0.057 | Eye Irritation: | 0.946 |
| Respiratory Toxicity: | 0.317 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC001495 | ![]() |
0.694 | D06GCK | ![]() |
0.380 | ||
| ENC006031 | ![]() |
0.694 | D04AIT | ![]() |
0.342 | ||
| ENC001622 | ![]() |
0.667 | D0FA2O | ![]() |
0.338 | ||
| ENC004732 | ![]() |
0.593 | D0G4KG | ![]() |
0.329 | ||
| ENC002207 | ![]() |
0.593 | D0K8KX | ![]() |
0.316 | ||
| ENC001617 | ![]() |
0.592 | D0N0OU | ![]() |
0.269 | ||
| ENC004786 | ![]() |
0.577 | D0Y7PG | ![]() |
0.253 | ||
| ENC001940 | ![]() |
0.569 | D0O6KE | ![]() |
0.247 | ||
| ENC001417 | ![]() |
0.534 | D07MGA | ![]() |
0.247 | ||
| ENC003878 | ![]() |
0.534 | D0G5UB | ![]() |
0.235 | ||